Technical CommentsCancer
Response to Comment on “PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL+ human leukemia”
- View ORCID ProfileDamian Lai1,2,
- View ORCID ProfileMin Chen1,
- View ORCID ProfileJiechuang Su1,3,
- View ORCID ProfileXiaohu Liu1,2,
- Katharina Rothe1,3,
- Kaiji Hu1,
- Donna L. Forrest2,4,
- View ORCID ProfileConnie J. Eaves1,2,3,
- View ORCID ProfileGregg B. Morin3,5 and
- View ORCID ProfileXiaoyan Jiang1,2,3,*
- 1Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada.
- 2Department of Medicine, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
- 3Department of Medical Genetics, University of British Columbia, Vancouver, BC V6H 3N1, Canada.
- 4Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver, BC V5Z 1M9, Canada.
- 5Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada.
- ↵*Corresponding author. Email: xjiang{at}bccrc.ca
See allHide authors and affiliations
Science Translational Medicine 17 Jul 2019:
Vol. 11, Issue 501, eaav0819
DOI: 10.1126/scitranslmed.aav0819
Vol. 11, Issue 501, eaav0819
DOI: 10.1126/scitranslmed.aav0819
Damian Lai
1Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada.
2Department of Medicine, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
Min Chen
1Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada.
Jiechuang Su
1Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada.
3Department of Medical Genetics, University of British Columbia, Vancouver, BC V6H 3N1, Canada.
Xiaohu Liu
1Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada.
2Department of Medicine, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
Katharina Rothe
1Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada.
3Department of Medical Genetics, University of British Columbia, Vancouver, BC V6H 3N1, Canada.
Kaiji Hu
1Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada.
Donna L. Forrest
2Department of Medicine, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
4Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver, BC V5Z 1M9, Canada.
Connie J. Eaves
1Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada.
2Department of Medicine, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
3Department of Medical Genetics, University of British Columbia, Vancouver, BC V6H 3N1, Canada.
Gregg B. Morin
3Department of Medical Genetics, University of British Columbia, Vancouver, BC V6H 3N1, Canada.
5Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada.
Xiaoyan Jiang
1Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada.
2Department of Medicine, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
3Department of Medical Genetics, University of British Columbia, Vancouver, BC V6H 3N1, Canada.
